Survival With Cemiplimab in Recurrent Cervical Cancer

for the Investigators for GOG Protocol 3016 and ENGOT Protocol En-Cx9

Research output: Contribution to journalComment/debate

1 Scopus citations
Original languageEnglish
Pages (from-to)348-350
Number of pages3
JournalObstetrical and Gynecological Survey
Volume77
Issue number6
DOIs
StatePublished - 1 Jun 2022
Externally publishedYes

Cite this